Nyxoah S.A. (NYXH)
$1.31-3.68%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $52M
- Beta
- 0.96
- P/E (TTM)
- -0.59
- Short % float
- 1.36%
- Days to cover
- 1.5
- SI change
- +19.7%
- 1W
- -7.09%
- 1M
- -14.94%
- vs SPY 1W
- -7.51%
- vs SPY 1M
- -17.00%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on NYXH?
- LOPJLB’s latest quantitative signal on Nyxoah S.A. (NYXH) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is NYXH in?
- Nyxoah S.A. (NYXH) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Nyxoah S.A. (NYXH) do?
- Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The companyâs lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, B…